These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19452666)

  • 1. Serotonin syndrome induced by duloxetine.
    Hadikusumo B; Ng B
    Aust N Z J Psychiatry; 2009 Jun; 43(6):581-2. PubMed ID: 19452666
    [No Abstract]   [Full Text] [Related]  

  • 2. Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.
    Jimenez-Genchi A
    J Clin Psychiatry; 2006 Nov; 67(11):1821-2. PubMed ID: 17196070
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion.
    Gollapudy S; Kumar V; Dhamee MS
    J Clin Anesth; 2012 May; 24(3):251-2. PubMed ID: 22537574
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypogonadism and gynecomastia with duloxetine.
    Weydt P; Schönfeldt-Lecuona CJ; Gahr M; Connemann BJ
    Pharmacopsychiatry; 2011 Mar; 44(2):77. PubMed ID: 21298612
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
    Himmighoffen H; Seifritz E; Boeker H
    Pharmacopsychiatry; 2011 Mar; 44(2):75-6. PubMed ID: 21161885
    [No Abstract]   [Full Text] [Related]  

  • 6. Duloxetine-induced cutaneous adverse reaction.
    Oulis P; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kouzoupis AV; Soldatos CR
    J Clin Psychopharmacol; 2008 Feb; 28(1):104-5. PubMed ID: 18204353
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 8. Burning paresthesia related to duloxetine therapy.
    Woo YS; Bahk WM
    J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin syndrome in an octogenarian after switch from fluoxetine to duloxetine.
    Liu PT; Argento V; Skudlarska B; Blagodatny M
    J Am Geriatr Soc; 2009 Dec; 57(12):2384. PubMed ID: 20122009
    [No Abstract]   [Full Text] [Related]  

  • 10. Suicidal ideation associated with duloxetine use: a case series.
    Parikh AR; Thatcher BT; Tamano EA; Liskow BI
    J Clin Psychopharmacol; 2008 Feb; 28(1):101-2. PubMed ID: 18204351
    [No Abstract]   [Full Text] [Related]  

  • 11. Duloxetine--three birds with one stone?
    Michel MC
    Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
    [No Abstract]   [Full Text] [Related]  

  • 12. Manic switching in patients receiving duloxetine.
    de Dios C; Ezquiaga E
    Am J Psychiatry; 2007 Jul; 164(7):1121. PubMed ID: 17606669
    [No Abstract]   [Full Text] [Related]  

  • 13. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.
    Strouse TB; Kerrihard TN; Forscher CA; Zakowski P
    J Clin Psychopharmacol; 2006 Dec; 26(6):681-3. PubMed ID: 17110838
    [No Abstract]   [Full Text] [Related]  

  • 15. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.
    Ravindran LN; Eisfeld BS; Kennedy SH
    J Clin Psychopharmacol; 2008 Feb; 28(1):107-8. PubMed ID: 18204355
    [No Abstract]   [Full Text] [Related]  

  • 16. Bleeding gums: duloxetine may be the cause.
    Balhara Y; Sagar R; Varghese ST
    J Postgrad Med; 2007; 53(1):44-5. PubMed ID: 17244971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.
    Karp JF; Whyte EM; Lenze EJ; Dew MA; Begley A; Miller MD; Reynolds CF
    J Clin Psychiatry; 2008 Mar; 69(3):457-63. PubMed ID: 18251622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
    Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine-induced excessive disturbing and disabling yawning.
    De Las Cuevas C; Sanz EJ
    J Clin Psychopharmacol; 2007 Feb; 27(1):106-7. PubMed ID: 17224733
    [No Abstract]   [Full Text] [Related]  

  • 20. Duloxetine: a dual reuptake inhibitor.
    Dugan SE; Fuller MA
    Ann Pharmacother; 2004 Dec; 38(12):2078-85. PubMed ID: 15522980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.